Management of Hyperglycemia-Induced Neurological Symptoms
Initial Assessment
- Evaluate for severity of hyperglycemia and presence of complications such as diabetic ketoacidosis (DKA) or hyperosmolar hyperglycemic state (HHS) by checking mental status, hydration status, and laboratory values 1
- Obtain laboratory tests including complete metabolic panel, serum ketones, arterial blood gas (if DKA suspected), and urinalysis 1
- Evaluate for potential precipitating factors such as infection, missed insulin doses, medications (corticosteroids, diuretics, beta-blockers), or intercurrent illness 2
Treatment of Hyperglycemia
- For blood glucose >200 mg/dL, initiate treatment to control hyperglycemia, as this level has been associated with neurological worsening 3, 4
- For severe hyperglycemia (>250 mg/dL), initiate intravenous insulin therapy with a bolus of regular insulin at 0.15 U/kg body weight, followed by continuous infusion at 0.1 U/kg/h 2
- Target glucose range of 140-180 mg/dL to avoid both hyperglycemia and hypoglycemia 1, 2
- For moderate hyperglycemia (140-250 mg/dL) without critical illness, subcutaneous insulin therapy may be appropriate, with basal insulin while initiating metformin for type 2 diabetes 1
- Avoid sulfonylureas when starting insulin therapy to prevent hypoglycemia 5
- Provide adequate fluid resuscitation with isotonic saline solution (0.9% NaCl) if dehydration is present 1, 2
- Monitor and replace electrolytes, particularly potassium, as total body deficits are common in hyperglycemic crises 2
Prevention of Recurrence
- Provide diabetes self-management education 1
- Consider combination therapy for patients with high A1C at diagnosis (>8.5%) to achieve more rapid glycemic control 1
- Educate patients on sick-day management, including when to contact healthcare providers, blood glucose targets, use of supplemental insulin during illness, and maintaining hydration 2
- Emphasize the importance of never stopping insulin during illness for insulin-dependent patients 2